Sandoz Italia company information, Employees & Contact Information

Sandoz acquisition to boost in-house biosimilar capabilities European Pharmaceutical Review

Evotec's $300M Biologics Deal with Sandoz Signals Major Shift to Asset-Light Strategy Stock Titan

Earnings call transcript: Sandoz Q1 2025 shows steady growth in biosimilars Investing.com

Novartis After Sandoz: The Business Without Generics (NYSE:NVS) Seeking Alpha

Sandoz Agrees on $275 Million Settlement in U.S. Price-Fixing Case The Wall Street Journal

Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site ACCESS Newswire

About Sandoz Sandoz

Sandoz: it’s time to HACk healthcare WIRED

Sandoz spin-off continues Novartis’ focus on innovation; $22bn purchase rumoured Pharmaceutical Technology

Novartis' Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe Fierce Pharma

Sandoz: stepping out from Novartis’ shadow The Pharma Letter

Coherus sells Lucentis biosimilar to Sandoz for $170M BioPharma Dive

A ‘Greenwich Village’ on the Prairie (Published 2023) The New York Times

Sandoz will pay $265m to settle price fixing case in US pharmaphorum

Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar Sandoz

The mobile app revolutionising healthcare access in Ghana WIRED

Sandoz recalls one lot of antibacterial drug cefazolin due to mispackaging Fierce Pharma

Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4 Fierce Pharma

Novartis, staring down tough market for M&A, leans toward $25B Sandoz spinoff: Bloomberg Fierce Pharma

Amid tough generics market, Sandoz to lay off 213 and shutter Eon Labs plant in North Carolina Fierce Pharma

Katherine Sandoz: The Swiss Army Painter The Bitter Southerner

Novartis unit teams up with medical marijuana producer, marking milestone for pharma statnews.com

‘De-integration’ of Sandoz from Novartis expected to include manufacturing cuts Fierce Pharma

Evotec, Sandoz expand biosimilar production pact inked last year Fierce Pharma

After setting out on its own, Sandoz inks $265M deal to resolve 'legacy' price-fixing lawsuit Fierce Pharma

Sandoz v . Amgen : What The Court Settled, What It Didn’t, And What Might Come Next Health Affairs

Sandoz breaks ground at $400M biosimilar site in Slovenia, where it'll hire 330 Fierce Pharma

Novartis nabs GSK executive for Sandoz CEO, bringing in a familiar face—and some digital prowess Fierce Pharma

Generics, Biosimilar Leader to Expand Access, Reduce Costs Mexico Business News

'Autonomous,' yes, but not for sale: Novartis won't sell Sandoz, CEO Vas Narasimhan says Fierce Pharma

Novartis' Sandoz goes digital from back office to 'not just apps,' therapeutics Fierce Pharma

Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June Fierce Pharma

Novartis' Sandoz spotlights importance of generic drugs in new social campaign Fierce Pharma

Sandoz Feels It Has The Ingredients To Make A Splash In ADCs Citeline News & Insights

Sandoz to shore up Europe’s last antibiotics plant Chemical & Engineering News

Coherus sells Lucentis biosim to Sandoz for $170M to focus on oncology Fierce Pharma

Sandoz looks to crowdsource digital health ideas with second hackathon at SXSW Fierce Pharma

Novartis decides Sandoz' future – and it's a spin-out pharmaphorum

Sandoz launches generic Revlimid in 19 countries in Europe, opening a flood of competition for BMS' megablockbuster Fierce Pharma

Boehringer Ingelheim and Sandoz abandon biosimilars Generics and Biosimilars Initiative

Novartis’ Sandoz Wins U.S. Approval for Neulasta Biosimilar BioSpace

Sandoz imports infant treatment from Canada after U.S. shortage arises Fierce Pharma

United Therapeutics teamed with pumpmaker to block Remodulin generics, Sandoz suit says Fierce Pharma

A $442M failure: After years of work and an FDA rejection, Novartis calls it quits on Advair copy Fierce Pharma

Amgen and Sandoz settle dispute over blockbuster bone condition drugs Life Sciences Intellectual Property Review

Joel Henri Sandoz Home served as first rectory for Holy Ghost Church Daily World | Opelousas News | dailyworld.com

Francis exits Sandoz, reigniting spinoff rumours PMLiVE

The Sandoz Opera House of old Opelousas Daily World | Opelousas News | dailyworld.com

Can Wooden People Bring Life to Taylor, Nebraska? Nebraska Public Media

Biocon expands Sandoz partnership to sell biosimilars in Australia The New Indian Express

Novartis to spin off Sandoz, list it in Zurich ET HealthWorld

Sandoz Growth Hormone Biosimilar Approved in Japan Genetic Engineering and Biotechnology News

Daniel Vasella European CEO

Sandoz drug shortage prompts Ottawa fast-track efforts CBC

Sandoz shuts unit near Mumbai Business Standard

Sandoz Buys 60% Stake In Systemix (Published 1991) The New York Times

AGP Limited says it has acquired 22 pharma brands from Sandoz AG Business Recorder